Team
Built by people who have stood at the operating table and at the FDA.
The problems this company works on were chosen by a surgeon who has spent a career managing their consequences, and the devices are engineered by people who have taken resorbable polymer products through preclinical development and regulatory submission before.
Leadership
Founders
Jill Kelley
Chief Executive Officer & Co-Founder
Leads the company across corporate development, capital formation, strategic partnerships and institutional engagement, and directs the federal and international relationships that support the portfolio.
Co-inventor on the issued U.S. patent underlying the platform.
Scott T. Kelley, MD, FACS
Board Chair
Surgical oncologist and Associate Professor of Surgery. Trained at Dartmouth College and Columbia University College of Physicians and Surgeons, with general surgery residency and research fellowships in cardiothoracic surgery and surgical oncology at the University of Pennsylvania, followed by surgical oncology fellowship at Moffitt Cancer Center.
At Moffitt he was the inaugural head of the esophagogastric oncology division, where he established the centre's first minimally invasive esophagectomy program and its first HIPEC program, directed surgical resident education, and served on NCCN guideline panels for esophageal and gastric cancer. Co-inventor on the issued U.S. patent underlying the platform.
Engineering & operations
Development team
Larry Scott, Jr., PhD
Biomedical Engineer
PhD in Molecular Physiology and Biophysics (cardiovascular sciences) from Baylor College of Medicine, with dual bachelor's degrees in biomedical engineering from Georgia Tech and applied physics from Morehouse College.
Previously product development engineer at PolyVascular, working on a polymeric transcatheter pulmonary valve across preclinical and GLP studies, FDA submissions and ISO 13485 design controls. Leads device design, bench characterisation and preclinical execution across the portfolio.
Dean Hu, MS
Operations, regulatory program management & CRO oversight
BS in bioengineering from UC San Diego and MS in bioengineering from Stanford. Named inventor on patents across fifteen families in the medical device field.
Co-founder of Spiracur, acquired in 2015; formerly senior director of research and innovation at Outset Medical and chief operating officer at Averto Medical. Supports EIG on operations, regulatory program management and contract research oversight.
Partners
Who we build with.
A small team is only credible with the right partners behind it. Materials, testing and preclinical execution run through organisations with established regulatory track records.
Bioresorbable polyesters supplied to implantable-device grade, with the documentation that supports regulatory submission.
Preclinical program design, biocompatibility strategy and regulatory support across the portfolio.
Mechanical and barrier-performance testing executed to written protocol by an accredited European laboratory.